A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

NCT05476783 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

119

Enrollment

INDUSTRY

Sponsor class

Stopped Resource Constraints

Conditions

Alzheimer's Disease

Interventions

DRUG: TB006

Sponsor

TrueBinding, Inc.